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ABSTRACT 
Rationale: Neurobiological models of addiction suggest that abnormalities of brain reward 
circuitry distort salience attribution and inhibitory control processes, which in turn contribute 
to high relapse rates. 
Objectives: To determine whether impairments of salience attribution and inhibitory control 
predict relapse in a pharmacologically unaided attempt at smoking cessation. 
Methods: 141 smokers were assessed on indices of nicotine consumption / dependence 
(e.g. the FTND, cigarettes per day, salivary cotinine), and three trait impulsivity measures.  
After overnight abstinence they completed experimental tests of cue reactivity, attentional 
bias to smoking cues, response to financial reward, motor impulsiveness, and response 
inhibition (antisaccades).  They then started a quit attempt with follow-up after 7 days, 1 
month, and 3 months; abstinence was verified via salivary cotinine levels ≤ 20ng/ml. 
Results: Relapse rates at each point were 52.5%, 64% and 76.3%.  The strongest 
predictor was pre-cessation salivary cotinine; other smoking / dependence indices did not 
explain additional outcome variance and neither did trait impulsivity.  All experimental 
indices except responsivity to financial reward significantly predicted one week outcome. 
Salivary cotinine, attentional bias to smoking cues and antisaccade errors explained unique 
as well as shared variance.  At one and three months, salivary cotinine, motor 
impulsiveness and cue reactivity were all individually predictive; the effects of salivary 
cotinine and motor impulsiveness were additive. 
Conclusions: These data provide some support for the involvement of abnormal cognitive 
and motivational processes in sustaining smoking dependence and suggest that they might 
be a focus of interventions, especially in the early stages of cessation. 
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INTRODUCTION 
More than 95% of smoking cessation efforts fail within a year (Hughes et al, 2004) despite 
an armoury of cessation aids and support systems, and there is thus a compelling need to 
identify individual relapse risk factors in order to refine and target treatments.  
Contemporary neurobiological models of addiction highlight abnormalities in the 
mesocorticolimbic ‘reward’ pathways which are activated by addictive substances (e.g. 
Koob and Nestler, 1997) but are hypoactive in abstinent drug users (e.g. Altmann et al, 
1996; Volkow et al., 2004).  Disturbances of the cognitive and behavioural processes 
mediated by these pathways, including attribution of salience to external stimuli and 
inhibitory control over behaviour, may contribute both to the development of dependence 
and to relapse. 
Salience attribution, attentional and motivational responses to incentive stimuli 
 
Goldstein & Volkow (2002) define salience attribution as “analysis of the information that 
carries emotive, evaluative, and, in the long-term, survival significance for the individual”.  A 
stimulus thus tagged with motivational significance elicits affective responses, 
corresponding approach or avoidance behaviours, and/or attentional biases.  Orbitofrontal 
cortex is strongly implicated as a key brain region involved in salience attribution, and is an 
important element of the interacting mesolimbic and mesocortical dopamine circuits 
collectively known as the brain reward system (e.g. Rose et al, 2007).  This system is 
activated during drug craving and shows structural and functional abnormalities in current 
and former users of many addictive substances including nicotine (e.g. Adinoff, 2004; Rose 
et al, 2007).  Volkow et al (2009) argue that addicts’ reward systems are hyporeactive and 
thus respond weakly to non-drug reinforcers, but, through a history of associative learning, 
respond disproportionately strongly to cues paired repeatedly with drug use.  This abnormal 
state will be most apparent when the individual has abstained from drug intake for at least a 
few hours so that the effects of the drug are no longer artificially increasing dopaminergic 
‘tone’.  The consequent imbalance between responsiveness to ‘normal’ and drug-related 
rewards may contribute to their difficulties in achieving and maintaining abstinence. 
There is plentiful evidence that users of addictive substances including alcohol, nicotine, 
and other drugs do show attentional biases to drug-related cues (e.g. Weinstein & Cox, 
2006) and respond to them with both increases in craving (e.g. Carter & Tiffany, 1999) and 
activation of mesocorticolimbic pathways and/or frontal cortex (e.g. Lingford-Hughes, 
2005).  Heightened awareness of cigarette availability coupled with powerful craving, if 
experienced early in cessation, is likely to undermine attempts at abstinence; indeed, 
laboratory indices of attentional bias have predicted relapse in some studies (Waters et al, 
2003a; Marissen et al, 2006) though not all (e.g. Waters et al., 2003b).  Likewise, stronger 
physiological or subjective responsiveness to smoking-related cues has sometimes 
predicted relapse or higher levels of consumption (e.g. Payne et al., 2006), but sometimes 
not (e.g. Niaura et al, 1999).   
If drug users’ mesocorticolimbic pathways are indeed hyporeactive, except when artificially 
stimulated by recent drug ingestion, they should, biologically, be less responsive to drug-
related cues when deprived or acutely abstinent.  However, the deprivation state may 
simultaneously elicit an expectancy-driven counter-directional effect in which the 
experience of withdrawal symptoms inflates the drug’s incentive value because of its 
capacity to give instant relief.   There is an extensive literature demonstrating that 
expectancies do indeed modulate both subjective craving (e.g. Droungas et al, 1995) and 
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neural reactions to drug-related cues (e.g. McBride et al, 2006).  Depending on the relative 
strength of these opposing effects, attentional bias and cue-elicited craving could increase, 
decrease, or be unchanged during abstinence.  In fact, the few studies which have 
compared smokers’ responses in abstinent versus satiated states have not found strong or 
consistent differences between them either for attentional bias (e.g. Field et al., 2004; Mogg 
& Bradley, 2002) or cue reactivity (e.g. Waters et al, 2004; Alsene et al., 2005).  It may well 
be that the effects of acute abstinence vary between individuals because of differences in 
factors affecting either their biological or psychological responses (e.g. severity of 
dependence; personality traits).  Regardless of what the determinants are, we hypothesise 
here that those smokers who experience the most pronounced attentional biases and cue 
reactivity during the early stages of a cessation attempt will be at heightened risk of early 
relapse. 
Assuming that drug ingestion acutely increases the overall reactivity of reward pathways in 
dependent drug users, it should enhance their biological responsiveness to all types of 
motivationally salient stimuli and not just to those which are drug-related.  By contrast, 
there is unlikely to be an opposing cognitive effect of abstinence on responses to non-drug 
stimuli since in general they will not be perceived as offering relief from withdrawal 
symptoms.  Consequently our group has previously hypothesised that acute (10-12 hours) 
abstinence from smoking should be associated with a straightforward reduction in smokers’ 
reactivity to non-drug stimuli compared to their reactivity after consuming nicotine via 
cigarette or lozenge.  We have found abstinence to be associated with diminished 
behavioural responses to financial incentive (Al-Adawi & Powell, 1997; Powell et al., 2002; 
Dawkins et al., 2006), reduced anticipation of enjoying everyday pleasures (Powell et al, 
2002), less attentional bias towards pleasure-related words (Powell et al., 2002; Dawkins et 
al, 2006), and decreased mood ‘uplift’ in response to positively toned film clips (Dawkins et 
al., 2007).  Similarly, Cook et al. (2007) reported that nicotine facilitated positive mood 
induction in anhedonic smokers.  There are however some studies which have not found 
such effects (e.g. Kalomboka et al, 2009), possibly reflecting differences in study designs, 
assessment procedures, or sample characteristics.   For example, smokers are likely to 
vary in the extent to which abstinence depresses their appetitive responses, perhaps as a 
function of pre-existing differences in personality and brain function, or variations in 
smoking history.   In any event, if some smokers do experience a loss of interest in non-
drug rewards and pleasures (anhedonia) during early cessation and are able to reverse this 
by smoking, then they are likely to be at elevated risk of relapse (e.g. Leventhal et al., 
2008).   
Response Inhibition / Inhibitory Control 
 
Increasing evidence of deficient inhibitory control (i.e. ability to suppress automatic but 
inappropriate responses) in drug users may likewise reflect dysregulation of frontostriatal 
brain regions (Volkow et al., 2008; Jentsch & Taylor, 1999; Yucel & Lubman, 2007).   
Relative to non-smokers, smokers have been found to be impaired on behavioural indices 
of impulse control in oculomotor (antisaccade), go/no-go, and delayed alternation tasks 
(e.g. Spinella, 2002), to take more risks in decision-making (Lejuez et al., 2003) and to 
show abnormally strong preferences for immediate or certain rewards over larger but 
delayed or less certain rewards (delay or probability discounting; e.g. Bickel et al., 1999; 
Mitchell, 1999; Reynolds et al., 2004).  These deficits, as with salience attribution, may be 
most evident in smokers during acute abstinence: thus smokers have shown lower 
antisaccade accuracy – indicating poorer inhibitory control - after 12 hours abstinence than 
after smoking (Powell et al., 2002) or consuming a nicotine lozenge (Dawkins et al., 2007), 
whilst Field et al. (2006) found their delay discounting of nicotine and monetary rewards to 
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be more pronounced during acute abstinence than after ad libitum smoking.  If these 
inhibitory control impairments affect the ability to restrain habitual real-world behaviours, 
then they will contribute to the difficulty smokers experience in resisting the urge to accept 
or reach out for a cigarette, especially during the early stages of a cessation attempt. 
Impulsivity is a complex personality trait often considered the behavioural phenotype of 
consistently weak inhibitory control.  Varying theoretical conceptualisations of the trait have 
given rise to impulsivity measures which intercorrelate only moderately or which fractionate 
into partially independent factors (e.g. Meda et al, 2009; Dawe et al, 2004).  Nevertheless, 
smokers generally score relatively highly on such scales (e.g. Lejuez et al, 2003; Mitchell, 
1999).  Whilst Doran et al. (2004) found one widely used measure of trait impulsivity to 
predict speed of relapse in adult smokers, Krishnan-Sarins et al (2007) found no such 
relationship in adolescents; interestingly, however, in this group relapse was predicted by 
two behavioural indices of impulsiveness (delay discounting and commission errors on a 
Continuous Performance Task).  There has been little other research directly investigating 
the relationship between impulsivity and relapse, and thus several tasks and trait measures 
have been employed here to provide at least a preliminary indication of whether some 
facets of the construct have more utility than others in predicting the ability to quit smoking. 
The present study 
 
This study explores the extent to which several indices of salience attribution and inhibitory 
control, measured immediately prior to an unassisted smoking cessation attempt, account 
for separate or overlapping variance in time to relapse.  Inter-relationships with other known 
prognostic factors, in particular physical and psychological dependence, are also of interest 
given that relapse risk is positively associated with self-report dependence measures (Piper 
et al, 2008), number of cigarettes per day (Myung et al, 2007), and level of craving during 
early abstinence (al'Absi et al., 2004).  Correlations with biological markers of nicotine 
consumption such as salivary cotinine have also been reported (Norregaard et al, 1993).   
Different indices of dependence and smoking behaviour intercorrelate with each other; for 
instance, Rubinstein et al (2007) found high correlations between various self-report 
measures and salivary cotinine.  This could reflect shared associations with 
mesocorticolimbic functioning.  Specifically, heavier nicotine intake may lead to greater 
neuroadaptation in mesocorticolimbic pathways, exacerbating motivational disturbances 
and anhedonia; and these aversive states may increase the individual’s self-reported 
dependence on smoking to enhance subjective well-being.  Despite evidence that indices 
of dependence and consumption correlate with one another, they have been found to be at 
least partially independent in moderate to heavy smokers (Donny et al, 2008); 
consequently several measures were included here. 
In addition to measuring the individual contributions of all these factors to relapse, logistic 
regression was used to investigate whether the behavioural indices of salience attribution 
and inhibitory control explained unique variance in outcome after controlling for level of 
dependence.   
METHODS 
Study Design 
This prospective investigation of relapse predictors was part of a larger project (Dawkins et 
al., 2006, 2007, 2009) in which 141 smokers were assessed after overnight abstinence on 
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two occasions a week apart, prior to commencement of an unaided quit attempt.  
Immediately before each assessment they consumed lozenges containing 4 mg or 0 mg 
nicotine (order counterbalanced; double-blind).  They were then tested on experimental 
measures of cue-elicited craving, salience attribution and response inhibition.  Scores in the 
placebo (0 mg) condition are indicative of the disturbances each individual smoker is likely 
to experience during early abstinence, and are the indices of interest in the present study. 
There was no effect of session order (i.e. whether participants had been tested in the 
placebo condition on the first or second occasion) on any of the indices reported upon here. 
Participants started their quit attempt immediately after the second assessment.  They were 
instructed not to use nicotine replacement or other medication, but no other forms of 
assistance were precluded and they were given written information about the symptoms 
and difficulties they might experience, together with some advice on non-pharmacological 
coping strategies.   
Follow-up assessments were at approximately 7 days, 30 days, and 3 months after the quit 
date.  Given that the principal objective of the study was to investigate predictive 
relationships between quantitative measures of functioning at baseline and success in 
becoming and remaining nicotine-free, it was decided to utilise a rather stringent definition 
of relapse which could be biologically verified with a reasonable degree of confidence, 
rather than the more forgiving definitions appropriate for evaluating interventions or the time 
course of cessation attempts (see, e.g. Hughes et al, 2003).   Participants reported on their 
cigarette consumption since the previous assessment and were classified as relapsers if 
they admitted to more than two cigarettes in any single week.  All those who did not were 
required to give a saliva sample for cotinine testing, and those with levels higher than 20 
ng/ml were also classified as relapsers.  Non-smokers have levels up to 13 ng/ml, each 
cigarette per day being associated with approximately an additional 14 ng/ml (Etter et al., 
2000), and after 7 days of continuous abstinence smokers’ levels are generally comparable 
with those of non-smokers (Abrams et al, 1987): thus the present cut-off is consistent with 
only minimal recent smoking.  These data thus assess the point prevalence of near-
complete abstinence over the preceding 7 days, an index which has been shown to 
correlate highly with indices of continuous and prolonged abstinence (Velicer and 
Prochaska, 2001).  In rare instances where salivary samples were missing, the participant 
was excluded from the analysis of outcome at that follow-up point.  Once a participant was 
deemed to have relapsed, his/her classification was not subsequently reversed even if s/he 
reported resumption of full abstinence. 
On each consecutive occasion, participants who remained abstinent were reassessed in 
order to investigate recovery of function (Dawkins et al, 2009).  There was a modest 
financial incentive to remain abstinent in that payments for consecutive assessments 
(which ceased following relapse) increased in size and were accumulated and paid only at 
the final meeting with the participant.  This helped to motivate attendance at follow-ups.  
Thus participants who relapsed before the first follow-up earned only £40 (for attending 
baseline and one follow-up assessment) whilst those abstaining throughout and completing 
all three follow-up assessments received £150.   
The study was approved by Goldsmiths Ethics Committee, and participants gave their 
informed consent.  In relation to the ethics of allocating smokers to an explicit ‘continue 
smoking’ condition, it should be noted that smokers were recruited from the community 
rather than from settings such as smoking clinics where their presence would have 
indicated an immediate intention or action plan to quit.  Individuals with specific health 
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problems contraindicating smoking were excluded, and participants allocated to the 
‘continue smoking’ condition were free to withdraw from the study in order to try and quit or 
cut down at any point, whilst still receiving payment for their participation until that point.  
Likewise participants allocated to the quit condition, which precluded use of nicotine 
replacement or other drug treatments, were free to withdraw from the study in order to use 
such aids whilst still being paid for their time and effort until that point.  
Participants 
Recruitment was via advertisements in the local community, a relatively deprived urban 
area in South London. Eligibility criteria were age 18 – 65, having smoked 10+ cigarettes 
per day over the preceding year; smoking within the first hour of waking; being willing to 
make an unaided quit attempt whether or not they were currently planning to do so; and 
being willing to continue smoking for the three month duration of the study if randomised to 
that condition.  Exclusion criteria were pregnancy, serious heart disease, recent stroke, 
prescribed psychoactive medication (e.g. antidepressants), regular use of UK “Class A” 
illicit recreational drugs (including heroin, cocaine, ecstasy, LSD, amphetamines), and pre-
cessation salivary cotinine levels below 40 ng/ml.   
Assessment measures 
 
Small amounts of data were missing for some variables, as shown in Table 1. 
Baseline (pre-cessation) 
 
Indices of smoking severity/dependence 
• Cigarettes smoked per day on average over the past year (self-report) 
• Salivary cotinine:  Cotinine concentrations in saliva samples were analysed by gas 
chromatography.   
• The Fagerström Test of Nicotine Dependence (FTND; Heatherton et al., 1991).  Scores 
on this self-report scale range from 0 to 10 (low to high dependence).    
• Dependence scale from the Smoking Motivation Questionnaire (SMQ; West & Russell 
1985).  Total scores range between 0 and 27 (high dependence).   
Trait impulsivity was assessed via subscale scores from three well-validated personality 
questionnaires tapping different but related facets of the construct:  
• The Sensation Seeking Scale (SSS; Zuckerman et al., 1978): Excitement-Seeking, 
Boredom Susceptibility, Thrill and Adventure Seeking, and Disinhibition subscales, plus 
the total score. 
• The Novelty Seeking subscale of the Tridimensional Personality Questionnaire (TPQ-
NS; Cloninger, 1987)  
• The Impulsivity subscale from the Impulsivity, Venturesomeness and Empathy 
questionnaire (IVE-Imp, Eysenck & Eysenck, 1991). 
Clinical and experimental indices assessed after 12 hours abstinence 
Full details are given in Dawkins et al (2006, 2007).  At the start of the session participants 
rated: 
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• Craving at that moment via the single item ‘How strong is your desire to smoke right 
now’; 1 = not at all strong; 7 = extremely strong.  Whilst craving is undoubtedly a 
complex construct (see, e.g., Shadel et al, 2001; Shiffman et al, 2004), single-item 
indices such as this have been found to be as sensitive and reliable as multi-item 
measures (West and Ussher, 2010) and have the practical benefits of simplicity and 
brevity. 
• Withdrawal symptoms at that moment, via the Mood and Physical Symptoms Scale 
(MPSS; West & Hajek, 2004); score range 0 to 28 (severe).   
• Mood over preceding week via the Hospital Anxiety and Depression Scale (Zigmond & 
Snaith, 1983).  Anxiety and Depression scores range from 0-21. 
Subsequent experimental measures comprised: 
Indices of salience attribution 
• Attentional bias to smoking related cues: This was assessed via a modified Stroop test 
(see Powell et al, 2002, for full details).  Participants colour-named the ink in which each 
of 88 words were printed on a single sheet of paper.  Four conditions, in 
counterbalanced order, utilised words of different types: neutral, appetitive, aversive, 
and smoking-related.  The construct of theoretical interest was attentional bias towards 
smoking-related stimuli [SmokeBias], indexed by subtracting colour-naming errors for 
neutral words [e.g. pavement, cadet] from those for smoking-related words [e.g. 
cigarette, lighter]. We focused on errors rather than speed given our previous finding 
(Dawkins et al, 2006) that acute abstinence affected the former but not the latter. 
• Cue reactivity: Craving elicited by smoking-related cues:  Participants rated their craving 
and withdrawal symptoms (as above) twice, following two-minute exposures firstly to a 
neutral cue (scotch tape) and secondly to a cigarette of their preferred brand; in both 
cases they took the cue from a box and smelled it.  Cue reactivity was the difference 
between the two ratings (smoking cue – neutral cue).  Presentation order was fixed so 
that the derived index was based on identical procedures for all participants. 
• Responsiveness to non-drug incentives: This was assessed via the Card Arranging 
Reward Responsivity Objective Test (CARROT; Al-Adawi & Powell 1997), which 
indexes the performance-enhancing effect of financial incentive.  Participants sorted 
cards according to a simple explicit rule under conditions of reward (R) and no reward 
(twice: NR1 and NR2) in the order NR1, R, NR2.  The card sorting rate (cards/second) 
in condition R relative to the average rate in NR1 and NR2 is the ‘reward responsivity’ 
index.  Again, the fixed presentation order means that this index is comparable across 
participants. 
Indices of inhibitory control 
• Oculomotor response inhibition: Fukushima et al’s (1994) antisaccade task was 
employed.  Participants were instructed to look either towards or away from a peripheral 
stimulus as quickly as possible after it flashed up on a computer screen.  Eye 
movements (saccades) were recorded using an infra-red reflection technique (IRIS IR 
6500 by Scalar Medical).  A first set of 60 stimuli were presented under prosaccade 
instructions, and after a five minute interval, a second set of 60 were presented under 
antisaccade instructions.  Any initial movement in the wrong direction constituted an 
error. The dependent variable used here was percentage errors in the antisaccade 
condition: this simple index of inhibitory control is impaired during acute abstinence (e.g. 
Dawkins et al, 2007). Trials where no eye movement was recorded were excluded, and 
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nine participants for whom data were missing for more than 50% of their trials were 
excluded from these analyses.  
• Motor impulsiveness:  Participants’ ability to inhibit maladaptive motor responses was 
assessed via Dougherty et al’s (1999) Continuous Performance Task (CPT). 5-digit 
numbers were presented visually at a rate of 2/sec for 5 minutes. ‘Targets’ (sequences 
with no obvious structure, e.g. 97528) were separated one from the next by three ‘filler’ 
stimuli of the fixed form 12345; participants had to press a button when two consecutive 
targets were identical.  ‘Motor impulsiveness’, manifesting as errors of commission to 
filler stimuli, was elevated in these smokers during acute abstinence (Dawkins et al, 
2007). Data were missing for nine participants. 
Statistical analyses 
Logistic regressions assessed the predictive relationship of each variable separately to 
outcome (continuous abstinence vs relapsed, with abstinence verified by salivary cotinine) 
at a week, a month, and 3 months.  Interrelationships between predictors were then 
investigated through a series of hierarchical logistic regressions (HLRs) constructed to 
address specific questions and to constrain the number of independent variables within 
each analysis.  In the first HLR, the four smoking / dependence measures were entered as 
predictors; only those which accounted for unique variance in outcome status were retained 
in subsequent HLRs investigating the joint contributions of individually significant predictors 
to outcome at each follow-up.  Participants with missing data on any variable in a given 
analysis were excluded from it; hence sample sizes vary between regressions. 
 
Additional correlational analyses were conducted to test specific hypotheses concerning 
relationships between smoking/dependence indices and other variables.  
 
RESULTS 
Participants 
65/141 (46.1%) were male.  109 (77.3%) described themselves as white, 8 (5.7%) as 
African-Caribbean, 10 (7.1%) as Asian, 2 (1.4%) as Hispanic, and 12 (8.5%) as ‘other’.   
Most continuous variables were approximately normally distributed.  Mean age was 33.2 ± 
12.8 years (range 18 – 65).  Self-reported daily cigarette consumption was 19.4 ± 7.1 
(range 10 – 40, median 17), and salivary cotinine at baseline was 285 ± 156 ng/ml (range 
44 – 940).  137 participants completed the FTND, the mean score being 5.1 ± 1.9 (median 
5, range 2 – 10).  Number of years smoking was slightly skewed to the left, with a mean of 
16.8 ± 13.0; the median was 12 years (range 1 – 50).  This was the first quit attempt for 31 
participants, with 84 (59.5%) having made 1-3 and nine (6.4%) 10+ previous attempts; on 
average they had made 2.4 ± 2.7 attempts.  About half used cannabis occasionally: and 
mean frequency of use in the last month was 5.6 ± 9.7 days.   
At each follow-up all participants who had been abstinent at the previous assessment were 
reassessed.  Cotinine levels for abstainers were mostly below 13 ng/ml (consistent with 
total abstinence), but slightly higher (13-20 ng/ml, indicative of occasional smoking) for six 
at a week, two at a month, and three at three months.  Samples were missing for two cases 
who claimed to be abstinent at one and three months, and they were excluded from 
analyses of outcome on the latter occasions.  Thus Ns were 141 at a week and 139 
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subsequently.  67 participants (47.5%) were abstinent at one week, 49 (35.2%) at a month, 
and 33 (23.7%) at 3 months.   
Relationship of individual variables to outcome 
Table 1 gives descriptive data for all variables assessed during acute abstinence at 
baseline; Table 2 shows their individual associations with outcome at each follow-up, and 
Table 3 shows the hierarchical linear regressions at each assessment point. 
 
Tables 1 and 2 about here 
 
Indices of smoking/dependence 
Relapse within 7 days was significantly predicted by pre-cessation salivary cotinine 
[SalCot], FTND score, and cigarettes per day; relapse within a month by SalCot and 
cigarettes per day; and relapse within three months only by SalCot.  SMQ-Dependence 
showed a near-significant association only with 7 day outcome. 
The four indices were significantly intercorrelated: salivary cotinine correlated at 0.44 with 
number of cigarettes per day, 0.42 with FTND scores and 0.25 with SMQ-Dependence; 
number of cigarettes per day correlated at 0.68 with the FTND and 0.38 with SMQ-
Dependence; and FTND correlated at 0.45 with SMQ-Dependence (p < 0.005 in all cases).  
In an HLR, the four smoking variables collectively explained about 13% of the variance in 
one-week outcome (χ 2 = 13.3, df = 4, p < 0.01; Nagelkerke pseudo R2 = 0.13). SalCot was 
the strongest predictor (χ 2 = 5.2, p < 0.03): all the others could be removed from the model 
without significant deterioration in fit (χ2 < 1, in each case).   This was likewise true at 1 and 
3 months.  
 
Table 3 about here 
 
Prediction of abstinence at one week 
Outcome at a week was unrelated to age, gender, trait impulsivity measures, and all clinical 
symptoms (mood, withdrawal symptoms, craving) measured during acute abstinence.  By 
contrast, it was significantly associated with scores on most of the experimental indices of 
motivational and inhibitory control in the acute abstinence baseline assessment, thus 
relapse was predicted by higher levels of cue reactivity and attentional bias towards 
smoking-related cues, and by weaker response inhibition as indicated by antisaccade 
errors and motor impulsiveness on the CPT.  These variables were uncorrelated with each 
other (r < 0.10, ns, for all pairs of variables).  Reward responsivity on the CARROT was the 
only experimental index not to predict outcome.    
The relationship of outcome to attentional bias was specific to smoking-related stimuli 
rather than reflecting a general tendency for attention to be captured by motivationally 
significant stimuli.  Thus outcome did not correlate with attentional bias towards either 
threat-related or pleasure-related words (indexed by subtracting error scores in these 
conditions from that in the neutral condition; χ2 = 2.9 and 0.4, ns, respectively). 
HLR investigated the combined explanatory power of all the individually significant 
predictors, including SalCot.  Complete data were available for 124 participants, of whom 
57 [46%] were abstainers and 67 [54%] relapsers.   Non-significant predictors were then 
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removed in a hierarchical series of regressions.  The final model retained SalCot, 
attentional bias, and antisaccade errors. Collectively these provided a significantly better fit 
to the data than an intercept-only model (χ 2 = 22.2, df = 3, p < 0.001), explaining about 
20% of the variance as indicated by a Nagelkerke pseudo R2 estimate of 0.20.  Further 
likelihood ratio tests demonstrated that none of the predictors could be removed without a 
significant deterioration in fit (χ 2 = 10.1, 5.8, and 4.0 respectively; p < 0.05 in each case).   
Table 3 shows the odds ratios, with 95% confidence intervals, for each of the predictors in 
the final model.  The odds of relapsing relative to remaining abstinent increased by 
approximately 0.4% for each 1 ng/ml increase in baseline cotinine levels, by about 30% for 
each additional ‘interference error’ produced by smoking-related words on the Stroop task, 
and by about 1.9% for every additional antisaccade error. 
For interest we additionally computed the relationships of outcome to scores on the same 
experimental indices assessed when participants were nicotine-satiated at baseline (i.e. 
after consumed the lozenge containing  4 mg nicotine). In this condition, only antisaccade 
errors significantly predicted relapse (χ2 = 5.2, p = 0.023).  
Prediction of abstinence at one month 
Of the demographic, clinical status, personality, and experimental variables, only cue 
reactivity and motor impulsiveness significantly predicted relapse at a month, though there 
was a similar trend for attentional bias to smoking cues (p < 0.06).  These three variables 
were entered with SalCot into an HLR based on 131 participants (34.4% abstainers, 65.6% 
relapsers) with complete data.  Only SalCot and motor impulsiveness were retained in the 
final model, which fitted the data significantly better than an intercept-only model (χ 2 = 
17.10, df = 2, p < 0.001); neither could be removed without significant deterioration in fit (χ2 
= 10.6 and 6.0; p < 0.02 in both cases), and they explained an estimated 17% of the 
variance (Nagelkerke pseudo R2 = 0.17).  As shown in Table 3, every 1 ng/ml increase in 
baseline cotinine levels increased the odds of relapse relative to abstinence by 
approximately 0.4%; and each additional impulsive motor error on the CPT increased the 
odds by 8%.  
Prediction of abstinence at three months 
Three variables remained individually significantly predictive of outcome at 3 months: 
SalCot, cue reactivity, and motor impulsivity.  An HLR based on 130 participants (30 
[23.1%] abstainers vs 100 [76.9%] relapsers) eliminated cue reactivity; the final model fitted 
the data significantly better than an intercept-only model (χ2 = 13.9, df = 2, p < 0.001), 
explaining an estimated 15% of the variance (Nagelkerke pseudo R2 = 0.15), and neither 
SalCot nor motor impulsiveness could be removed without significant deterioration in fit (χ2= 
8.9 and 4.6 respectively; p < 0.04 in both cases).  Table 3 shows that the odds of relapsing 
relative to remaining abstinent increased by 0.5% for every 1 ng/ml increase in baseline 
cotinine levels, and by 8.5% for each additional impulsive motor error on the CPT.  
DISCUSSION 
A handful of previous studies have found cue reactivity, attentional bias to smoking-related 
cues, or indices of inhibitory control assessed experimentally to be predictive of relapse to 
smoking (e.g. Payne et al, 2006; Marissen et al, 2006; Krishnan-Sarins et al, 2007).  The 
present study, however, is the first to have assessed the predictive relevance of all these 
variables concurrently in a prospective study controlling for level of dependence.   
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As anticipated, indices of nicotine consumption and dependence were strong predictors of 
relapse, reflecting the well-established tendency for heavier smokers to have the greatest 
difficulty quitting. The finding that pre-cessation cotinine levels predicted relapse more 
strongly than either subjective ratings of nicotine dependence or the severity of self-
reported somatic and affective withdrawal symptoms is consistent with previous research 
showing daily cigarette consumption and salivary cotinine to stronger predictors than self-
report dependence measures (e.g. Breslau and Johnson, 2000; Nollen et al, 2006).  These 
data suggest that underlying biological factors are greater influences on continued smoking 
than are the associated subjective aspects of dependence.   
Whilst salivary cotinine levels were the strongest predictor of outcome, attentional bias 
towards smoking-related cues and poor inhibitory control over simple motor responses 
during acute abstinence explained additional unique variance. Strikingly, these 
experimental indices, and also cue reactivity, were stronger predictors of relapse within a 
week than were severity of withdrawal symptoms, craving, and low mood during acute 
abstinence, or trait impulsivity.   
Analyses of outcome predictors focused on the experimental indices assessed during acute 
abstinence, given that any difficulties experienced in this state are the ones with which 
smokers have to contend in order to remain abstinent.  Theoretically, it is also during early 
abstinence that underlying abnormalities of brain functioning are likely to be unmasked.  
These assumptions are consistent with the finding that participants’ scores on the same 
indices after recent nicotine intake (via a 4 mg lozenge) were markedly less predictive of 7 
day outcome than were scores during acute abstinence. Indeed, only one of the indices 
(antisaccade error rate) predicted relapse when assessed in the satiated condition; cue 
reactivity, attentional bias to smoking cues, and motor impulsiveness were not predictive, 
by contrast with their predictive effects when assessed during acute abstinence. 
The absence of intercorrelations between the four cognitive / motivational predictors of 
outcome reflects previous published findings (e.g. McDonald et al., 2003) and is difficult to 
reconcile straightforwardly with the theoretical premise that they are all similarly influenced 
by abnormalities of functioning in shared mesocorticolimbic brain circuitry.   Whilst 
differences between tasks in terms of non-shared processes, content, or procedural details 
will tend to weaken associations, the lack of evidence for even modest interrelationships 
suggests either that the processes putatively tapped by the tasks do not depend on shared 
neuronal mechanisms or that the tasks are not, after all, sensitive to those processes. At 
the very least the present data indicate that attentional bias towards smoking-related stimuli 
and the craving elicited by them are independent aspects of salience attribution, and that 
antisaccade errors and failure to inhibit manual motor responses in the Continuous 
Performance Task tap different and unrelated facets of inhibitory control.  Dissociations 
between inhibitory control indices similar to those used here have been reported and 
discussed by other groups (e.g. Nigg et al, 2002; Chiakzoe et al, 2007); the latter group, for 
example, explored the dissociation between a go/no-go task (similar to the CPT) and 
antisaccade performance, noting that the former but not the latter consistently activates 
right lateral prefrontal cortex.  By experimentally varying task protocols, they found 
evidence that the relevant distinction is the extent to which a ‘preparatory set’ is instigated 
prior to stimulus presentation (stronger in the antisaccade than the go/no-go task).    
Functional neuroimaging studies may in time explain these theoretically unexpected 
process dissociations.  At a practical level, however, it is interesting to consider how and 
why performance on these laboratory-based tasks are predictive of relapse.  Perhaps they 
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simply do “what they say on the tin”: that is, the Stroop index of attentional bias to smoking-
related words reflects the extent to which newly abstinent smokers are tuned in to cues of 
cigarette availability; the experimental cue reactivity index reflects the craving they 
experience in response to real world cues of cigarette availability; CPT–motor 
impulsiveness indexes difficulties in motor control akin to those that smokers have in 
inhibiting their overlearned behavioural tendency to reach out for a cigarette when it is 
available; and antisaccade errors reflect difficulties in overriding prepotent responses (such 
as lighting up), by substituting an alternative and incompatible action.   However, whilst this 
account offers a plausible description of how processes tapped by the individual tasks may 
jointly conspire to increase the likelihood of relapse, it begs the question of their 
unexpected lack of covariation; clearly this is an issue demanding much further 
investigation. 
The only experimental variable which did not predict relapse at any point was reward 
responsiveness, indexed by the degree to which monetary reward enhanced card-sorting 
(CARROT) performance.  This measure was depressed during acute abstinence in the 
present sample (Dawkins et al, 2006), consistent with down-regulation of their reward 
system.  We conjectured that if abstainers experience this state (apathy) as aversive, they 
might experience heightened temptation to smoke in order to restore normal hedonic tone 
or drive state and hence be at elevated risk of relapse. The present negative findings 
contradict this hypothesis.  It is possible that generalised impairments of motivation might, 
by contrast, reduce abstainers’ likelihood of engaging in planning and actions necessary to 
smoke when cigarettes are not immediately available; if so, these two opposing effects of 
apathy could offset one another in terms of overall relapse risk.  This would, however, be 
difficult to verify, and for all practical purposes the conclusion must be that impairment of 
reward responsiveness per se has little or no relevance to successful abstinence. 
None of the three self-report impulsivity measures predicted relapse. Smokers are typically 
high in trait impulsivity (e.g. Gurpegui et al, 2007; Mitchell, 1999), but only two previous 
studies have investigated its relevance to smoking cessation. Both used the Barratt 
Impulsivity Scale: Doran et al. (2004) found it to be positively correlated with rapidity of 
relapse in 45 adult smokers with a history of depression, but Krishnan-Sarin et al (2007) 
found no association with one-month cessation rates in 30 adolescents.  The present 
sample was larger and more representative of adult smokers, and the use of multiple 
questionnaires enabled the potential impact of several different conceptualisations of 
impulsivity to be investigated.  The contrast between the failure of any of these scales to 
predict relapse and the predictive significance of several behavioural indices is consistent 
with other evidence of such dissociations in the context of impulsivity and substance use 
(e.g. McDonald et al, 2003; Reynolds et al., 2006; Verdejo-Garcia et al., 2008).  In 
particular, Krishnan-Sarin likewise found neurocognitive measures of impulsivity to 
outperform trait measures in predicting relapse to smoking, as did Goudriaan et al (2008) in 
relation to gambling.  From a clinical perspective, therefore, these findings suggest that 
whilst many smokers may have an impulsive personality, cessation-related interventions 
might most productively focus on abnormalities in objectively measurable cognitive and 
motivational processes such as those found here to predict relapse. 
A general methodological problem for studies such as this, which employ multiple indices of 
putative underlying processes, is that there is no way of being certain that the indices are 
comparable in accuracy, sensitivity, or reliability.  The absence of an expected relationship 
with relapse might thus reflect inadequate psychometric properties or poor construct validity 
of the predictor variable; likewise, a stronger relationship with one index than with another 
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could reflect their differing sensitivities rather than a real difference in the importance of the 
corresponding processes.  It would therefore be premature to infer simply from the 
magnitude of different correlations that motor impulsiveness is more important to relapse 
than cue reactivity, or that reward responsiveness is irrelevant: future research employing 
better or different measures may reveal different patterns.  Relatedly, procedural factors – 
often unavoidable - are likely to compromise the sensitivity of some experimental indices.  
For instance, high levels of craving at baseline may have reduced the scope for cue 
reactivity in some participants. The emergence of significant associations despite such 
measurement problems is therefore quite compelling evidence for the relevance of the 
variables concerned and suggests that the observed effect sizes may be conservative 
indications of the real importance of these processes.     
It is interesting that the unique contributions to relapse risk made by cognitive / motivational 
processes assessed during acute abstinence were more pronounced in the first week of 
the cessation attempt, whilst the predictive utility of pre-cessation systemic nicotine levels 
remained fairly constant across all three follow-up points.  One possible explanation is that 
there is more rapid recovery of cognitive and motivational processes tapped by our 
experimental measures than in some other aspects of functioning so that those smokers 
who maintain abstinence over the early period are subsequently less affected by their early 
motivational and cognitive vulnerability.  Thus, if some of the biological abnormalities 
associated with smoking – whether they pre-existed the onset of smoking or were to some 
extent smoking-induced – are relatively long-lasting they are rather likely to exert a 
persistent effect on relapse risk.  On the other hand, it is possible that recovery in some 
aspects of brain function precedes others, and that the experimental measures employed 
here are sensitive to those early changes.  In this regard, it is pertinent that abstinent 
alcoholics show substantial cognitive recovery over a matter of weeks or a few months (e.g. 
Mann et al., 1999) even though they remain at high risk of relapse for much longer.  The 
present sample was unfortunately not of sufficient size for this explanation to be tested, so 
it remains purely speculative.  From a purely clinical perspective, however, it is noteworthy 
that whilst the predictive impact of attentional bias and antisaccade error rate declined from 
one follow-up to the next, motor impulsiveness and cue reactivity remained predictive of 
relapse right up to three months.  The effect of cue reactivity appears to reflect underlying 
biological factors, since it did not explain additional variance over and above that explained 
by baseline salivary cotinine.  However, this does not render it uninteresting – indeed, 
rather the reverse.  Pre-existing biological risk factors such as prior nicotine consumption 
are not themselves modifiable, but the processes they underpin and which are the proximal 
drivers of behaviour may well be more susceptible to intervention.  Thus if, as suggested by 
these findings, heightened cue reactivity is in part a reflection of dependence and is one of 
the important processes by which dependence leads to increased relapse risk, then it 
makes sense to try either to modify the cue reactivity itself or to equip the individual with 
strategies to contend with it.  Motor impulsiveness was to some extent independent of 
dependence, explaining additional variance in outcome, and is therefore likewise an 
important candidate for treatment focus in supportive interventions which extend beyond 
the very early stages of cessation. 
Abstinence rates of 47.5% at a week, 35.2% at a month, and 23.7% at 3 months are at or 
above the upper end of the range reported in studies of unassisted cessation; thus Hughes 
et al (2004) report rates at the corresponding intervals of 24-51%, 15-28%, and 10-20%.  It 
is likely that the combination of repeated assessments and the participation payment 
schedule, which withheld payment until the end of the study and gave incrementally greater 
financial rewards to those who abstained for longer, contributed to this; monetary incentives 
appear to boost cessation rates over three months (e.g. Lamb et al, 2007) although there is 
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little evidence that they impact positively on long-term abstinence (Cahill and Perera, 
2008).  We did not determine whether participants had used any specific forms of treatment 
or support during their abstinence attempt, though they were instructed not to use nicotine 
replacement therapy or other medication.  Whilst the present study in any case lacked the 
statistical power to evaluate possible moderator effects of different treatments on the 
relationships between predictors and relapse, it is an important issue for future research.   
Given that half of all participants had – as elsewhere (e.g. Hughes et al., 2004) – relapsed 
within the first week, interventions prior to and during the first week of a cessation attempt 
might valuably focus on the cognitive and motivational variables which significantly 
predicted early relapse.  Clinicians could consider assessing individual smokers on each of 
these indices prior to their cessation attempt in order both to inform them of their personal 
risks and to tailor advice and support accordingly.  For example, a smoker who performs 
poorly on an inhibitory control task and shows pronounced attentional bias to smoking cues 
could be helped to develop strategies to avoid or handle situations where cigarettes are 
available.   Such advice, whilst not in itself innovative and part of many cognitive-
behavioural interventions, could take on particular motivational force if the individual has 
been pre-assessed as having the relevant personal risk factor(s).  It is  further worth 
considering in particular whether quitters might specifically be assisted to enhance their 
inhibitory control via techniques focusing on general alertness - for example, making a 
conscious effort to regulate sleeping habits, limiting alcohol intake, increasing physical 
activity, engaging in mentally stimulating activities, and possibly even judicious 
consumption of some caffeinated drinks. 
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TABLE 1:  Scores on experimental measures 
 
Variable N Mean    s.d. Minimum Maximum 
Trait measures of impulsivity      
IVE-Impulsivity 134 9.33 4.23 1.0 18.0 
TPQ-Novelty Seeking 136 19.54 5.32 8.0 33.0 
SSS-Total score 132 23.03 6.88 3.0 38.0 
Symptoms during acute abstinence      
HADS-Depression [range 0-21] 141 4.26 2.91 0.0 11.0 
HADS-Anxiety [range 0-21] 141 6.54 3.48 0.0 16.0 
Withdrawal symptoms [MPSS; range 0-28] 140 6.39 4.20 0.0 18.0 
Craving [range 1-7] 141 4.08 1.81 1.0 7.0 
Experimental indices during acute abstinence      
Cue reactivity (increase in craving from neutral to smoking cue) 141 0.80 1.08 -2.0 4.0 
CARROT reward responsivity (cards/sec) 141 0.013 0.68 -0.21 0.16 
Stroop: Interference from smoking cues (errors) 140 -0.14 1.36 -4.0 3.0 
Antisaccade accuracy (% correct) 132 65.87 20.31 5.0 98.0 
CPT MotImp (false hits) 132 6.44 8.55 0.0 76.0 
 
Abbreviations: IVE - Impulsivity, Venturesomeness and Extraversion questionnaire; TPQ – Tridimensional Personality Questionnaire; SSS 
– Sensation Seeking Scale; HADS – Hospital Anxiety and Depression Questionnaire; MPSS – Mood and Physical Symptoms Scale; 
CARROT – Card Arranging Reward Responsivity Objective Test; CPT MotImp – Continuous Performance Test, motor impulsiveness
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TABLE 2:  Predictors of outcome at a week, a month, and three months 
 
One week abstinence 
(67 abstinent; 74 relapsed) 
One month abstinence  
(49 abstinent;  89 relapsed) 
3 months abstinence  
(33 abstinent; 106 relapsed) Variable 
χ2 N p χ 2 N p χ 2 N p 
Demographic and smoking indices 
              
Age 2.29 141 .130   0.12 139 .726   0.61 139 .436  
Gender 0.41 141 .523   0.00 139 .975   0.05 139 .820  
No. cigarettes per day 4.72 141 .030 *  5.00 139 .025 *  1.90 139 .170  
Salivary cotinine pre-quit 12.03 141 .001 ***  13.26 139 .000 ***  9.81 139 .002 *** 
FTND 8.21 137 .004 ***  3.36 135 .067   1.63 135 .200  
SMQ-dependence 3.34 140 .067   0.50 138 .481   0.28 138 .600  
Trait measures of impulsivity               
IVE-Impulsivity 0.18 134 .670   0.07 132 .792   0.38 132 .537  
TPQ-Novelty Seeking 0.06 136 .812   0.21 134 .646   0.50 134 .479  
SSS-Total score1 0.71 132 .399   0.33 130 .566   0.27 130 .606  
Symptoms during acute abstinence               
HADS-Depression 0.07 141 .798   0.12 139 .728   0.56 139 .453  
HADS-Anxiety 1.98 141 .159   0.43 139 .510   0.34 139 .560  
Withdrawal symptoms 0.24 140 .625   0.30 138 .584   0.03 138 .860  
Craving 2.63 141 .110   0.65 139 .419   2.80 139 .094  
Experimental indices during acute abstinence               
Cue reactivity (craving) 5.08 141 .024 *  6.80 139 .009 **  6.05 139 .014 * 
CARROT reward responsivity 0.34 141 .561   0.01 139 .941   0.92 139 .336  
Stroop: Interference from smoking cues 6.78 140 .009 **  3.58 138 .059   0.05 138 .821  
Antisaccade accuracy 5.65 132 .017 *  1.38 130 .240   0.16 130 .688  
CPT MotImp 6.47 132 .011 **  7.32 131 .007 **  4.99 130 .026 * 
 
* p < 0.05; ** p < 0.01; *** p < 0.001 
Abbreviations: FTND – Fagerstrom Test of Nicotine Dependence; SMQ – Smoking Motivation Questionnaire; IVE - Impulsivity, Venturesomeness and Extraversion 
questionnaire; TPQ – Tridimensional Personality Questionnaire; SSS – Sensation Seeking Scale; HADS – Hospital Anxiety and Depression Questionnaire; MPSS – 
Mood and Physical Symptoms Scale; CARROT – Card Arranging Reward Responsivity Objective Test; CPT MotImp – Continuous Performance Test motor 
impulsiveness 
1None of the four subscales showed significant correlations with outcome at any follow-up point 
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TABLE 3:  Predictors of abstinence at each follow-up point 
 
 
95% Confidence Interval for 
odds ratio  B Standard Error Wald df p 
Odds 
Ratio Lower Bound Upper Bound 
7 DAYS         
Intercept   .289 .770 0.141 1 .707    
Salivary cotinine (pre-quit)   .004 .001 8.950 1 .003 1.004 1.001 1.007 
Stroop: Interference from smoking cues   .351 .151 5.385 1 .020 1.421 1.056 1.911 
Antisaccade accuracy -.019 .010 3.804 1 .050 0.981 0.962 1.000 
ONE MONTH         
Intercept -.980 .474 4.27 1 .039    
Salivary cotinine (pre-quit)   .004 .001 8.86 1 .003 1.004 1.002 1.007 
CPT MotImp1   .086 .040 4.69 1 .030 1.090 1.008 1.178 
THREE MONTHS         
Intercept  -.476 .517 0.85 1 .357    
Salivary cotinine (pre-quit)   .005 .002 7.32 1 .007 1.005 1.001 1.008 
CPT MotImp   .089 .047 3.58 1 .058 1.093 0.997 1.198 
 
1CPT MotImp: Continuous Performance Test, motor impulsivity 
 
